JEFFREY M JONAS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEFFREY M JONAS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEFFREY M JONAS. JEFFREY M JONAS is Executive Vice President in IONIS PHARMACEUTICALS INC ($ISIS) and Chief Innovation Officer in Sage Therapeutics, Inc. ($SAGE) and President & CEO in Sage Therapeutics, Inc. ($SAGE) and See Remarks in Sage Therapeutics, Inc. ($SAGE) and Director in Generation Bio Co. ($GBIO) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX).
Latest Insider Trading Transactions of JEFFREY M JONAS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GBIO, ISIS, KRTX, SAGE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Option Exercise | M | 0.45 | 12,000 | 5,400 | 46,587 | |
| Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Buy | M | 0.45 | 12,000 | 5,400 | 75,237 | 63.2 K to 75.2 K (+18.98 %) |
| Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Payment of Exercise | F | 58.80 | 3,093 | 181,868 | 63,237 | 66.3 K to 63.2 K (-4.66 %) |
| Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Grant | A | 0.00 | 10,000 | 0 | 66,330 | 56.3 K to 66.3 K (+17.75 %) |
| Feb 12 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Option Exercise | A | 82.27 | 34,000 | 2,797,180 | 34,000 | |
| Jan 28 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Option Exercise | M | 0.45 | 1,800 | 810 | 58,587 | |
| Jan 28 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Buy | M | 0.45 | 1,800 | 810 | 56,330 | 54.5 K to 56.3 K (+3.30 %) |
| Jun 15 2020 | GBIO | Generation Bio Co. | JONAS JEFFREY M | Director | Option Exercise | A | 19.00 | 52,000 | 988,000 | 52,000 | |
| Jun 08 2020 | KRTX | Karuna Therapeutic ... | JONAS JEFFREY M | Option Exercise | A | 97.59 | 12,500 | 1,219,875 | 12,500 | ||
| Apr 30 2020 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 39.87 | 15,385 | 613,400 | 15,385 | |
| Apr 30 2020 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 39.87 | 15,385 | 613,400 | 15,385 | |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | P | 64.20 | 7,500 | 481,500 | 54,530 | 47 K to 54.5 K (+15.95 %) |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | P | 64.20 | 7,500 | 481,500 | 54,530 | 47 K to 54.5 K (+15.95 %) |
| Sep 12 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 4,600 | 2,070 | 60,387 | |
| Sep 12 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 4,600 | 2,070 | 47,030 | 42.4 K to 47 K (+10.84 %) |
| Jul 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Payment of Exercise | F | 161.38 | 1,685 | 271,925 | 42,430 | 44.1 K to 42.4 K (-3.82 %) |
| Jul 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Grant | A | 0.00 | 5,000 | 0 | 44,115 | 39.1 K to 44.1 K (+12.78 %) |
| Jul 17 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 27,000 | 12,150 | 64,987 | |
| Jul 17 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 27,000 | 12,150 | 39,115 | 12.1 K to 39.1 K (+222.86 %) |
| Jul 01 2019 | KRTX | Karuna Therapeutic ... | JONAS JEFFREY M | Director | Option Exercise | A | 16.00 | 16,250 | 260,000 | 16,250 | |
| Jun 25 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 47.70 | 23,100 | 1,101,870 | 46,200 | |
| May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 35,736 | 16,081 | 91,987 | |
| May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 171.39 | 475 | 81,411 | 12,115 | 12.6 K to 12.1 K (-3.77 %) |
| May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 170.40 | 400 | 68,158 | 12,590 | 13 K to 12.6 K (-3.08 %) |
| May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 169.16 | 200 | 33,832 | 12,990 | 13.2 K to 13 K (-1.52 %) |
| May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 177.62 | 2,545 | 452,033 | 13,190 | 15.7 K to 13.2 K (-16.17 %) |
| May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 176.44 | 11,662 | 2,057,674 | 15,735 | 27.4 K to 15.7 K (-42.57 %) |
| May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 175.72 | 16,651 | 2,925,880 | 27,397 | 44 K to 27.4 K (-37.80 %) |
| May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 174.48 | 28,293 | 4,936,667 | 44,048 | 72.3 K to 44 K (-39.11 %) |
| May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 173.62 | 25,510 | 4,428,934 | 72,341 | 97.9 K to 72.3 K (-26.07 %) |
| May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 35,736 | 16,081 | 97,851 | 62.1 K to 97.9 K (+57.53 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 40,356 | 18,160 | 127,723 | |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 53,908 | 24,259 | 168,079 | |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 177.76 | 950 | 168,872 | 62,115 | 63.1 K to 62.1 K (-1.51 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 176.80 | 2,518 | 445,182 | 63,065 | 65.6 K to 63.1 K (-3.84 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 175.79 | 3,974 | 698,589 | 65,583 | 69.6 K to 65.6 K (-5.71 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 175.02 | 24,966 | 4,369,549 | 69,557 | 94.5 K to 69.6 K (-26.41 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 174.05 | 7,948 | 1,383,349 | 94,523 | 102.5 K to 94.5 K (-7.76 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 40,356 | 18,160 | 102,471 | 62.1 K to 102.5 K (+64.97 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 176.15 | 1,763 | 310,552 | 62,115 | 63.9 K to 62.1 K (-2.76 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 175.09 | 14,727 | 2,578,550 | 63,878 | 78.6 K to 63.9 K (-18.74 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 174.46 | 31,099 | 5,425,532 | 78,605 | 109.7 K to 78.6 K (-28.35 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 173.41 | 4,200 | 728,322 | 109,704 | 113.9 K to 109.7 K (-3.69 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 172.20 | 1,619 | 278,792 | 113,904 | 115.5 K to 113.9 K (-1.40 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 171.01 | 500 | 85,505 | 115,523 | 116 K to 115.5 K (-0.43 %) |
| May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 53,908 | 24,259 | 116,023 | 62.1 K to 116 K (+86.79 %) |
| Feb 15 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 157.63 | 50,000 | 7,881,500 | 50,000 | |
| Jan 10 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 10,000 | 4,500 | 221,987 | |
| Jan 10 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 10,000 | 4,500 | 62,115 | 52.1 K to 62.1 K (+19.19 %) |
| Dec 11 2018 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 47.70 | 23,100 | 1,101,870 | 23,100 | |
| Apr 04 2018 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 145.77 | 90,000 | 13,119,300 | 90,000 | |
| Dec 26 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 50,000 | 22,500 | 232,552 | |
| Dec 26 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 50,000 | 22,500 | 51,226 | 1.2 K to 51.2 K (+4,078.30 %) |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 12,753 | 5,739 | 282,552 | |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 110,247 | 49,611 | 295,305 | |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 155.00 | 12,753 | 1,976,715 | 1,226 | 14 K to 1.2 K (-91.23 %) |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 12,753 | 5,739 | 13,979 | 1.2 K to 14 K (+1,040.21 %) |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 162.59 | 599 | 97,391 | 1,226 | 1.8 K to 1.2 K (-32.82 %) |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 162.08 | 5,000 | 810,400 | 1,825 | 6.8 K to 1.8 K (-73.26 %) |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 160.36 | 13,049 | 2,092,538 | 6,825 | 19.9 K to 6.8 K (-65.66 %) |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 159.53 | 22,334 | 3,562,943 | 19,874 | 42.2 K to 19.9 K (-52.91 %) |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 158.21 | 33,301 | 5,268,551 | 42,208 | 75.5 K to 42.2 K (-44.10 %) |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 157.48 | 27,152 | 4,275,897 | 75,509 | 102.7 K to 75.5 K (-26.45 %) |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 156.55 | 71,823 | 11,243,891 | 102,661 | 174.5 K to 102.7 K (-41.16 %) |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 155.48 | 36,989 | 5,751,050 | 174,484 | 211.5 K to 174.5 K (-17.49 %) |
| Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 110,247 | 49,611 | 211,473 | 101.2 K to 211.5 K (+108.91 %) |
| Feb 08 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 47.70 | 140,000 | 6,678,000 | 140,000 | |
| Dec 16 2016 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Option Exercise | A | 38.25 | 43,200 | 1,652,400 | 324,000 | |
| Feb 10 2016 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Option Exercise | A | 28.63 | 60,000 | 1,717,800 | 60,000 | |
| Jan 07 2016 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Option Exercise | M | 0.45 | 20,000 | 9,000 | 400,360 | |
| Jan 07 2016 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | M | 0.45 | 20,000 | 9,000 | 101,226 | 81.2 K to 101.2 K (+24.62 %) |
| Jan 07 2016 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | P | 49.56 | 226 | 11,201 | 81,226 | 81 K to 81.2 K (+0.28 %) |
| Jul 24 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 76.79 | 3,000 | 230,370 | 81,000 | 84 K to 81 K (-3.57 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Option Exercise | M | 0.45 | 147,971 | 66,587 | 0 | |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Option Exercise | M | 0.45 | 128,629 | 57,883 | 0 | |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | M | 0.45 | 45,255 | 20,365 | 84,000 | 38.7 K to 84 K (+116.80 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | M | 0.45 | 32,745 | 14,735 | 38,745 | 6 K to 38.7 K (+545.75 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 75.51 | 29,303 | 2,212,766 | 6,000 | 35.3 K to 6 K (-83.00 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 76.09 | 64,973 | 4,943,705 | 35,303 | 100.3 K to 35.3 K (-64.79 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 76.85 | 14,146 | 1,087,096 | 100,276 | 114.4 K to 100.3 K (-12.36 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 78.13 | 6,804 | 531,570 | 114,422 | 121.2 K to 114.4 K (-5.61 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | M | 0.45 | 115,226 | 51,852 | 121,226 | 6 K to 121.2 K (+1,920.43 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 78.22 | 11,329 | 886,173 | 6,000 | 17.3 K to 6 K (-65.38 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 78.88 | 62,364 | 4,919,116 | 17,329 | 79.7 K to 17.3 K (-78.26 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 79.97 | 5,707 | 456,387 | 79,693 | 85.4 K to 79.7 K (-6.68 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 81.51 | 2,420 | 197,246 | 85,400 | 87.8 K to 85.4 K (-2.76 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Sell | S | 83.89 | 1,554 | 130,361 | 87,820 | 89.4 K to 87.8 K (-1.74 %) |
| Jun 17 2015 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Buy | M | 0.45 | 83,374 | 37,518 | 89,374 | 6 K to 89.4 K (+1,389.57 %) |
| Jan 04 2008 | ISIS | IONIS PHARMACEUTIC ... | JONAS JEFFREY M | Executive Vice Pres ... | Option Exercise | A | 15.38 | 78,936 | 1,214,036 | 78,936 | |
| Feb 05 2007 | ISIS | IONIS PHARMACEUTIC ... | JONAS JEFFREY M | Executive Vice Pres ... | Option Exercise | A | 10.77 | 130,000 | 1,400,100 | 130,000 |
Page: 1